BOCOUTURE 100 units powder for solution for injection
Authorisation PA1907/003/002 · Merz Pharmaceuticals GmbH
- Licence holder
- Merz Pharmaceuticals GmbH (all products →)
- Dosage form
- Powder for solution for injection
- Route of administration
- Intramuscular use
- ATC code
- M03AX01
- First authorised
- 12/02/2021
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 5 years (since 12 February 2021). The HPRA list marks it as marketed in Ireland.
Other medicines with CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS in Ireland
1 other product on the HPRA list contains CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS, from 1 licence holder; 1 of them is marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| BOCOUTURE 50 units powder for solution for injection | Merz Pharmaceuticals GmbH | National authorisation (PA) | Marketed |
The licence holder
Merz Pharmaceuticals GmbH holds 14 products on the HPRA list, with 6 different active substances; 5 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.